BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 8932773)

  • 1. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
    Hertz CJ; Mansfield JM
    Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
    Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
    J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
    Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kühn R; Müller W; Trinchieri G; Sher A
    J Immunol; 1996 Jul; 157(2):798-805. PubMed ID: 8752931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.
    Uzonna JE; Kaushik RS; Gordon JR; Tabel H
    J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
    Abrahamsohn IA; Coffman RL
    J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma.
    Shibata Y; Foster LA; Kurimoto M; Okamura H; Nakamura RM; Kawajiri K; Justice JP; Van Scott MR; Myrvik QN; Metzger WJ
    J Immunol; 1998 Oct; 161(8):4283-8. PubMed ID: 9780204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
    Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
    Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host genetics and resistance to acute Trypanosoma cruzi infection in mice: profiles and compartmentalization of IL-2-, -4-, -5-, -10-, and IFN-gamma-producing cells.
    Eksi S; Wassom DL; Powell MR
    J Parasitol; 1996 Feb; 82(1):59-65. PubMed ID: 8627502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi.
    Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC
    J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parasite antigen-induced IFN-gamma and IL-4 production by cells from pathopermissive and pathoresistant strains of mice infected with Trypanosoma cruzi.
    Humphrey JS; McCormick TS; Rowland EC
    J Parasitol; 1997 Jun; 83(3):533-6. PubMed ID: 9194843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production.
    Zhang L; Tarleton RL
    Eur J Immunol; 1996 Jan; 26(1):102-9. PubMed ID: 8566051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
    Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
    Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis.
    Namangala B; Noël W; De Baetselier P; Brys L; Beschin A
    J Infect Dis; 2001 Jun; 183(12):1794-800. PubMed ID: 11372033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.